6578 Background: Due to improved lymphoma cure rates, long-term toxicity, including iathrogenic sterility, is of great concern. We thus evaluated the fertility of patients (pts) treated for HD at the Istituto Nazionale Tumori of Milan from 1990 to 2001 with three different chemotherapy (CT) regimens +/- radiotherapy excluding pelvic nodes. Material and Methods: The case series included 191 pts (73 males,118 females), median age 27 years (range 18–45), in long-lasting complete remission after three different CT regimens: 119 pts received 4–6 cycles of ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine); 48 pts were given 6–8 cycles of VEBEP (VP16, epirubicin, bleomycin, cyclophosphamide, prednisone) and 25 pts were treated with sequential CT including intermediate-high doses of epirubicin, vincristine, prednisone, cyclophosphamide and etoposide for a 3 months period. Fertility was evaluated by semen analysis and conceptions in males and by history of menstrual cycles and pregnancies in females. WHO criteria were used to classify normospermia, azoospermia, abnormal semen (all sperm abnormalities but azoospermia), amenorrhea and normorrhea. Results: Males: after ABVD we observed permanent azoospermia in 6%, abnormal semen in 70% and normal semen in 24%; 30% of pts fathered. After VEBEP we documented permanent azoospermia in 35%, abnormal semen in 46% and normal semen in 19%; 27% of pts fathered. After sequential CT permanent azoospermia occurred in 33% and abnormal semen in 67%; 11% of pts fathered. Females: definitive amenorrhea was documented in 2% after ABVD, 17% after VEBEP and 6% after sequential CT; all pts who became amenorrheic were aged > 30 years at treatment. Pregnancies occurred in 38%, 21% and 25% in each treatment group respectively. Conclusions: Long-term results confirm that ABVD spares fertility in the majority of cases. Regimens containing alkylating agents, like VEBEP or sequential CT, induce sterility in less than 20% of women, but in a large fraction of male pts. Therefore pretreatment cryopreservation of semen should be offered to all males. No significant financial relationships to disclose.